Independent Guidance For Veterans & FamiliesNot Affiliated With The VA

VA BENEFITS REFERENCE

The Skin: Shared Criteria For DC 7806 Through 7824

Read the skin criteria for DC 7806 through 7824: 9 listed codes, their distinct instructions, shared formulas and official notes.

Independent Education · Official Sources · Last Verified October 25, 2026

Published criteria from 38 CFR 4.118, current through 2026-10-22. Historical decisions may require a different version. This reference does not diagnose a condition or determine an evaluation.

The Skin · All Diagnostic Codes

DC 7806: Dermatitis Or Eczema

Diagnostic code 7806 addresses Dermatitis or eczema. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7806 - 38 CFR 4.118
Rating
7806 Dermatitis or eczema.
Evaluate under the General Rating Formula for the Skin

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7806, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7809: Discoid Lupus Erythematosus

Diagnostic code 7809 addresses Discoid lupus erythematosus. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7809 - 38 CFR 4.118
Rating
7809 Discoid lupus erythematosus.
Evaluate under the General Rating Formula for the Skin
Note: Do not combine with ratings under DC 6350

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7809, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7813: Dermatophytosis (Ringworm: Of Body, Tinea Corporis; Of Head, Tinea Capitis; Of Feet, Tinea Pedis; Of Beard Area, Tinea Barbae; Of Nails, Tinea Unguium (Onychomycosis); Of Inguinal Area (Jock Itch), Tinea Cruris; Tinea Versicolor)

Diagnostic code 7813 addresses Dermatophytosis (ringworm: Of body, tinea corporis; of head, tinea capitis; of feet, tinea pedis; of beard area, tinea barbae; of nails, tinea unguium (onychomycosis); of inguinal area (jock itch), tinea cruris; tinea versicolor). Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7813 - 38 CFR 4.118
Rating
7813 Dermatophytosis (ringworm: Of body, tinea corporis; of head, tinea capitis; of feet, tinea pedis; of beard area, tinea barbae; of nails, tinea unguium (onychomycosis); of inguinal area (jock itch), tinea cruris; tinea versicolor).
Evaluate under the General Rating Formula for the Skin

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7813, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7815: Bullous Disorders (Including Pemphigus Vulgaris, Pemphigus Foliaceous, Bullous Pemphigoid, Dermatitis Herpetiformis, Epidermolysis Bullosa Acquisita, Benign Chronic Familial Pemphigus (Hailey-Hailey), And Porphyria Cutanea Tarda)

Diagnostic code 7815 addresses Bullous disorders (including pemphigus vulgaris, pemphigus foliaceous, bullous pemphigoid, dermatitis herpetiformis, epidermolysis bullosa acquisita, benign chronic familial pemphigus (Hailey-Hailey), and porphyria cutanea tarda). Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7815 - 38 CFR 4.118
Rating
7815 Bullous disorders (including pemphigus vulgaris, pemphigus foliaceous, bullous pemphigoid, dermatitis herpetiformis, epidermolysis bullosa acquisita, benign chronic familial pemphigus (Hailey-Hailey), and porphyria cutanea tarda).
Evaluate under the General Rating Formula for the Skin
Note: Rate complications and residuals of mucosal involvement (ocular, oral, gastrointestinal, respiratory, or genitourinary) separately under the appropriate diagnostic code

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7815, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7816: Psoriasis

Diagnostic code 7816 addresses Psoriasis. Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7816 - 38 CFR 4.118
Rating
7816 Psoriasis.
Evaluate under the General Rating Formula for the Skin
Note: Rate complications such as psoriatic arthritis and other clinical manifestations (e.g., oral mucosa, nails) separately under the appropriate diagnostic code

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7816, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7820: Infections Of The Skin Not Listed Elsewhere (Including Bacterial, Fungal, Viral, Treponemal, And Parasitic Diseases)

Diagnostic code 7820 addresses Infections of the skin not listed elsewhere (including bacterial, fungal, viral, treponemal, and parasitic diseases). Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7820 - 38 CFR 4.118
Rating
7820 Infections of the skin not listed elsewhere (including bacterial, fungal, viral, treponemal, and parasitic diseases).
Evaluate under the General Rating Formula for the Skin

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7820, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7821: Cutaneous Manifestations Of Collagen-Vascular Diseases Not Listed Elsewhere (Including Scleroderma, Calcinosis Cutis, Subacute Cutaneous Lupus Erythematosus, And Dermatomyositis)

Diagnostic code 7821 addresses Cutaneous manifestations of collagen-vascular diseases not listed elsewhere (including scleroderma, calcinosis cutis, subacute cutaneous lupus erythematosus, and dermatomyositis). Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7821 - 38 CFR 4.118
Rating
7821 Cutaneous manifestations of collagen-vascular diseases not listed elsewhere (including scleroderma, calcinosis cutis, subacute cutaneous lupus erythematosus, and dermatomyositis).
Evaluate under the General Rating Formula for the Skin

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7821, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7822: Papulosquamous Disorders Not Listed Elsewhere (Including Lichen Planus, Large Or Small Plaque Parapsoriasis, Pityriasis Lichenoides Et Varioliformis Acuta (PLEVA), Lymphomatoid Papulosus, Mycosis Fungoides, And Pityriasis Rubra Pilaris (PRP))

Diagnostic code 7822 addresses Papulosquamous disorders not listed elsewhere (including lichen planus, large or small plaque parapsoriasis, pityriasis lichenoides et varioliformis acuta (PLEVA), lymphomatoid papulosus, mycosis fungoides, and pityriasis rubra pilaris (PRP)). Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7822 - 38 CFR 4.118
Rating
7822 Papulosquamous disorders not listed elsewhere (including lichen planus, large or small plaque parapsoriasis, pityriasis lichenoides et varioliformis acuta (PLEVA), lymphomatoid papulosus, mycosis fungoides, and pityriasis rubra pilaris (PRP)).
Evaluate under the General Rating Formula for the Skin

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7822, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

DC 7824: Diseases Of Keratinization (Including Icthyoses, Darier's Disease, And Palmoplantar Keratoderma)

Diagnostic code 7824 addresses Diseases of keratinization (including icthyoses, Darier's disease, and palmoplantar keratoderma). Read its specific instructions together with any shared formula, notes and linked provisions. These criteria describe evaluation after the applicable entitlement requirements are met; this reference does not diagnose a condition or determine a claim.

Diagnostic Code 7824 - 38 CFR 4.118
Rating
7824 Diseases of keratinization (including icthyoses, Darier's disease, and palmoplantar keratoderma).
Evaluate under the General Rating Formula for the Skin

Read the shared provisions referenced by this code: General Skin Formula.

What The Criteria Measure

  • Does the decision identify diagnostic code 7824, and does the medical record describe the condition named by this code?
  • Do records identify the treatment, procedure and relevant dates that the provision actually distinguishes?
  • Have the code-specific notes and cross-references been read before comparing any listed evaluation?

Related Public DBQs

Editorial subject matches, not official VA code-to-form assignments. Read the form scope and clinician instructions.

Regulatory Cross-References

General Skin Formula

Referenced by DC 7806, DC 7809, DC 7813, DC 7815, DC 7816, DC 7820, DC 7821, DC 7822, DC 7824. Apply only as each code directs, including its conditions and exceptions.

General Skin Formula - 38 CFR 4.118
Rating
General Rating Formula For The Skin For DCs 7806, 7809, 7813-7816, 7820-7822, and 7824:
At least one of the following60
Characteristic lesions involving more than 40 percent of the entire body or more than 40 percent of exposed areas affected; or
Constant or near-constant systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, psoralen with long-wave ultraviolet-A light (PUVA), or other immunosuppressive drugs required over the past 12-month period60
At least one of the following30
Characteristic lesions involving 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected; or Systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, over the past 12-month period
At least one of the following10
Characteristic lesions involving at least 5 percent, but less than 20 percent, of the entire body affected; or
At least 5 percent, but less than 20 percent, of exposed areas affected; or
Intermittent systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12-month period
No more than topical therapy required over the past 12-month period and at least one of the following0
Characteristic lesions involving less than 5 percent of the entire body affected; or
Characteristic lesions involving less than 5 percent of exposed areas affected
Or rate as disfigurement of the head, face, or neck (DC 7800) or scars (DCs 7801, 7802, 7804, or 7805), depending upon the predominant disability. This rating instruction does not apply to DC 7824

Shared Rules And Regulatory Context

Context provisions do not create an additional evaluation automatically assigned to every condition.

Related Guides

Official Sources

Last verified 2026-10-25. Source publication or legal effective dates are shown separately where available.

Check The Source. Get Accredited Help.

Use this resource to understand published information. VA and the official decision control individual benefits.